Product Name: JNJ-26076713
Description: JNJ-26076713 is an orally active alpha V integrin antagonist. JNJ-26076713 represents a potential therapeutic candidate for the treatment of age-related macular degeneration, macular edema, and proliferative diabetic retinopathy.
CAS NO: 79804-71-0 Product: Corticotropin-releasing factor (ovine)
Synonym: JNJ-26076713; JNJ26076713; JNJ 26076713.
IUPAC Chemical Name: 3-Quinolinepropanoic acid, 1,2,3,4-tetrahydro-beta-((1-(1-oxo-3-(1,5,6,7-tetrahydro-1,8-naphthyridin-2-yl)propyl)-4-piperidinyl)methyl)-, (betaS,3S)-
In ChiKey: HIV Integrase inhibitors
SMILE Code: O=C(O)C[C@H](CC1CCN(C(CCC2=CC=C3CCCN=C3N2)=O)CC1)[C@H]4CNC5=C(C=CC=C5)C4
Appearance: Solid powder
Purity: 98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.Medchemexpress
Storage Condition: Dry, dark and at 0 – 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: 2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 – 4 C for short term (days to weeks), or -20 C for long term (months).PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/22128294
Chemical Formula：C29H38N4O3
ExactMass: 490.29439
Molecular Weight: 490.64
Elemental Analysis: C, 70.99; H, 7.81; N, 11.42; O, 9.78
bet-bromodomain.com
BET Bromodomain Inhibitor
